StockNews.AI
ZBH
StockNews.AI
81 days

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025

1. ZBH declares a quarterly cash dividend of $0.24 per share. 2. Dividend payable on July 31, 2025, for record holders on June 26, 2025. 3. Company emphasizes innovation and technology in medical solutions. 4. ZBH operates in 25+ countries and serves over 100 countries. 5. Proven leadership of over 90 years strengthens ZBH's market position.

-0.89%Current Return
VS
-0.28%S&P 500
$91.76505/30 09:35 AM EDTEvent Start

$90.9506/02 10:07 AM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bullish?

The announced dividend signals financial health and shareholder value, reflecting positively on ZBH's stock. Historically, dividend announcements often correlate with increased investor confidence and can lead to stock price appreciation.

How important is it?

The dividend declaration reinforces ZBH's financial stability, likely attracting income-focused investors. This is particularly relevant given the ongoing trend toward rewarding shareholders and could enhance stock attractiveness.

Why Short Term?

The immediate payment of dividends affects liquidity and investor sentiment in the short term. Previous dividend announcements in the sector have shown stock price increases shortly after the announcement.

Related Companies

, /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2025. The cash dividend of $0.24 per share is payable on or about July 31, 2025 to stockholders of record as of the close of business on June 26, 2025. About Zimmer Biomet Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.  With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet. SOURCE Zimmer Biomet Holdings, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News